NCT04941170

Brief Summary

Administration of opioids for the treatment of acute pain after open umbilical hernia repair is associated with many side effects. Erector spinae plane (ESP) block is a novel inter-fascial plane block used in postoperative pain and chronic neuropathic pain relief of the thoracoabdominal region.TAP block is a regional injection of local anaesthetic between the transversus abdominis and internal oblique muscle planes. TAP block affects the sensory nerves of the anterolateral abdominal wall (T6-L1) that innervate the abdomen.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P25-P50 for phase_4 pain

Timeline
Completed

Started Jun 2021

Shorter than P25 for phase_4 pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 19, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 28, 2021

Completed
1 day until next milestone

Study Start

First participant enrolled

June 29, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2021

Completed
Last Updated

May 6, 2022

Status Verified

May 1, 2022

Enrollment Period

4 months

First QC Date

June 19, 2021

Last Update Submit

May 4, 2022

Conditions

Keywords

Open umbilical herniaTransversus abdominis plane blockErector spinae plane block

Outcome Measures

Primary Outcomes (1)

  • total morphine consumption.

    Amount of morphine used as rescue analgesia post-operatively.

    in first 24 hours

Secondary Outcomes (3)

  • Intraoperative fentanyl consumption

    From the start of operation till its end up to 3 hours.

  • time of first analgesic request

    in 24 hours

  • pain severity evaluation.

    at PACU admission , 30 minutes , 2 hours , 4 hours , 8 hours ,12 hours ,18 hours and 24 hours post operative

Study Arms (2)

Group (T)

ACTIVE COMPARATOR

receive preoperative bilateral ultrasound-guided oblique subcostal transversus abdominis plane block.

Drug: BupivacainDrug: Bupivacaine

Group (E)

ACTIVE COMPARATOR

receive preoperative bilateral ultrasound-guided erector spinae plane block.

Drug: BupivacainDrug: Bupivacaine

Interventions

Ultrasound-guided oblique subcostal transversus abdominis plane block will be performed in the supine position under strict aseptic precautions. placing a linear high-frequency ultrasound probe obliquely near the costal margin and xiphoid process On confirming the placement of the needle in the correct target space, 1 mL of 0.25% bupivacaine will be injected to hydro-dissect the fascia layer between the RA and TA. After confirming the separation of the transversus abdominis fascia plane, the remaining 19 mL of 0.25% bupivacaine will be administered, advancing the needle infero-laterally parallel to the subcostal margin. A similar procedure will be performed on the contralateral side of the abdomen with an injection of another 20 mL of 0.25% bupivacaine.

Also known as: oblique subcostal transversus abdominis plane block
Group (E)Group (T)

Ultrasound-guided erector spinae plane block will be performed in the sitting position. T7 spinous process will be located To perform the block. The tip of the T7 transverse process will be then identified using the ultrasound probe that is placed in a transverse orientation The ultrasound transducer will then be placed in a longitudinal orientation 2-3 cm lateral to the midline in a longitudinal orientation to identify the hyperechoic line of the transverse process with its associated acoustic shadow. After local anaesthetic infiltration, the block needle will be inserted in a craniocaudal direction until contact will be achieved with the T 7 transverse process where the tip will lay in the inter-fascial plane below the erector spinae muscle. A small bolus of local anaesthetic should be given through the block needle to confirm the proper needle position. A total of 20 mL bupivacaine 0.25% will be injected into the interfacial plane deep to the erector spinae muscle bilaterally.

Also known as: erector spinae plane block
Group (E)Group (T)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • American Society of anesthesiologists I-II, scheduled for open umbilical hernia repair.
  • Age range of 18-65 years.

You may not qualify if:

  • patient refusal.
  • Patients belonging to ASA grade III and grade IV.
  • Extreme obesity (BMI \>35).
  • hepatic or renal insufficiency.
  • preoperative cognitive dysfunction or communication disorder.
  • allergy to amide-type local anaesthetics.
  • back puncture site infection.
  • Coagulation disorders, pregnancy, drug abusers.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Banha Faculity of Medicine

Banhā, Elqalyoubea, 13511, Egypt

Location

MeSH Terms

Conditions

PainHernia, Umbilical

Interventions

Bupivacaine

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesHernia, VentralHernia, AbdominalHerniaPathological Conditions, Anatomical

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Officials

  • fatma ah abdelfatah, MD

    Benha University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Double-blinded
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

June 19, 2021

First Posted

June 28, 2021

Study Start

June 29, 2021

Primary Completion

November 1, 2021

Study Completion

December 15, 2021

Last Updated

May 6, 2022

Record last verified: 2022-05

Locations